Suppr超能文献

人泪液中组织蛋白酶抑制剂-1 的存在与水样液缺乏性干眼病诊断的相关性:一项初步研究。

Presence of Histatin-1 in Human Tears and Association with Aqueous Deficient Dry Eye Diagnosis: A Preliminary Study.

机构信息

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, USA.

Research Resources Center, University of Illinois at Chicago, Chicago, USA.

出版信息

Sci Rep. 2019 Jul 16;9(1):10304. doi: 10.1038/s41598-019-46623-9.

Abstract

The aims of this study were to determine if histatin-1 (H1) is present in normal human tears and whether tear levels of H1 varied between normal patients and those with aqueous deficient dry eye disease (ADDE). Patient samples were obtained from 11 normal patients and 11 severe ADDE patients. Relevant patient characteristics, including age, sex, and dry eye disease (DED) diagnostic parameters were collected. Multiple qualitative and quantitative methods were used to compare the concentration of H1 between patient groups. Mixed linear modeling was used to compare H1 levels between groups, and diagnostic performance was assessed using the receiver-operator-characteristic (ROC). ADDE patients had significantly lower H1 concentrations (85.9 ± 63.7 ng/ml) than the normal group (891.6 ± 196.5 ng/ml) (p < 0.001), while controlling for age and sex. ROC analysis indicated that H1 concentration is potentially a biomarker for ADDE (area under curve = 0.96). Reclassification of patients by DED parameters including, Ocular Surface Disease Index (OSDI) (≤13, >13) and Schirmer I (without anesthesia) (<10 mm, ≥10 mm) showed significant differences in H1 level (OSDI, p = 0.004) and Schirmer I ((p = 0.010). In conclusion, this is the first preliminary report of the presence of H1 in human tears. H1 concentrations are lower in ADDE patients and H1 may have diagnostic potential in evaluation ADDE patients.

摘要

本研究旨在确定组织蛋白酶抑制蛋白-1(H1)是否存在于正常人的泪液中,以及 H1 的泪液水平是否在正常患者和水液缺乏性干眼病(ADDE)患者之间存在差异。患者样本取自 11 名正常患者和 11 名严重 ADDE 患者。收集了相关的患者特征,包括年龄、性别和干眼病(DED)诊断参数。采用多种定性和定量方法比较了两组患者 H1 浓度的差异。采用混合线性模型比较了组间 H1 水平,并采用接收者操作特征(ROC)评估了诊断性能。ADDE 患者的 H1 浓度(85.9±63.7ng/ml)明显低于正常组(891.6±196.5ng/ml)(p<0.001),同时控制了年龄和性别因素。ROC 分析表明,H1 浓度可能是 ADDE 的潜在生物标志物(曲线下面积=0.96)。根据包括眼表面疾病指数(OSDI)(≤13、>13)和 Schirmer I 试验(无麻醉)(<10mm、≥10mm)在内的 DED 参数对患者进行重新分类,H1 水平存在显著差异(OSDI,p=0.004)和 Schirmer I 试验(p=0.010)。总之,这是首次初步报道 H1 存在于人泪液中。ADDE 患者的 H1 浓度较低,H1 可能具有评估 ADDE 患者的诊断潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff86/6635511/7a151236aa64/41598_2019_46623_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验